Published: May 6th 2024 | Updated: May 21st 2024
FDA Accepts BLA for Subcutaneous Nivolumab Across Various Solid Tumors
Published: January 6th 2023 | Updated: October 4th 2024
Bridging Options for CAR T-Cell Therapy in R/R DLBCL
Published: October 1st 2024 | Updated: October 4th 2024
Clinical Considerations with Axtilimab in R/R GVHD
Published: September 4th 2024 | Updated: October 4th 2024
Breaking Down the Barriers to Effective T-Cell Lymphoma Treatment
Published: September 4th 2024 | Updated: October 4th 2024
Risk Factors and Indications for Stem Cell Transplants in MDS
Published: September 5th 2024 | Updated: October 4th 2024
Improved Sensitivity Leads to Expanded MRD Use in Lymphoma